行情

BFRA

BFRA

Biofrontera
NASDAQ

实时行情|Nasdaq Last Sale

9.90
0.00
0.00%
已收盘, 16:00 12/13 EST
开盘
--
昨收
10.14
最高
--
最低
--
成交量
15
成交额
--
52周最高
18.32
52周最低
9.00
市值
4.44亿
市盈率(TTM)
-376.6122
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BFRA 新闻

  • 沪指高开高走 美财长称未将美元武器化
  • 新浪财经.2小时前
  • 挪威电信称华为仍将参与挪威5G建设
  • 新浪财经综合.7小时前
  • 苹果特斯拉等遭集体诉讼 因供应商非法雇佣童工
  • 新浪科技.7小时前
  • 新西兰证券交易所因连接问题暂停所有交易
  • 新浪财经.7小时前

更多

所属板块

制药
-0.74%
制药与医学研究
-0.32%

热门股票

名称
价格
涨跌幅

BFRA 简况

Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The Company is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The Company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.
展开

Webull提供Biofrontera AG的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。